Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Centogene NV CNTGF

Healthcare
Centogene N.V., is a commercial company. The company focuses on rare diseases, transforming clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The company's platform includes epidemiological, phenotypic, and genetic data reflecting a global population, as well as a biobank of blood samples from these patients. The company's... see more

Recent & Breaking News (OTCQB:CNTGF)

CENTOGENE Signs Strategic Transaction With Private Equity Group Charme Capital Partners

GlobeNewswire 8 days ago

CENTOGENE Data on Novel Genetic Risk Factor for Parkinson's Disease in The Lancet Neurology

GlobeNewswire September 25, 2024

CENTOGENE Receives Delisting Notice From Nasdaq

GlobeNewswire August 7, 2024

CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson's Disease Cases Are Linked to Genetic Factors

GlobeNewswire August 1, 2024

C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development

GlobeNewswire June 20, 2024

CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting

GlobeNewswire May 31, 2024

CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights

GlobeNewswire May 15, 2024

CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position

GlobeNewswire May 15, 2024

CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease

GlobeNewswire May 14, 2024

CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients

GlobeNewswire May 10, 2024

CENTOGENE Receives Nasdaq Non-Compliance Notice

GlobeNewswire April 2, 2024

CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders

GlobeNewswire March 19, 2024

CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency

GlobeNewswire February 29, 2024

CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing

GlobeNewswire February 28, 2024

CENTOGENE Explores Strategic Alternatives

GlobeNewswire February 28, 2024

CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration

GlobeNewswire January 25, 2024

CENTOGENE Receives French Research Tax Credit Accreditation

GlobeNewswire January 24, 2024

CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson's Disease Using Multiomics

GlobeNewswire January 23, 2024

CENTOGENE Announces Preliminary Full Year 2023 Revenue

GlobeNewswire January 18, 2024

CENTOGENE Announces Voting Results of Extraordinary General Meeting

GlobeNewswire December 19, 2023